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A b s t r a c t  
This review discusses recent advances in biosensor technology which draw on the disciplines of 
physics, chemistry, biochemistry and electronics. We first show that a biosensor consists of three 
components, a biological detection system, a transducer and an output system. Biological receptors 
are reviewed, followed by a detailed discussion of transducers, optical, electrochemical, 
piezoelectric, and others which involve interesting physics and show particular promise for 
commercial biosensors, are discussed thoroughly. New developments in biosensor design are 
appearing at a high rate as these devices play increasingly important roles in daily life. We describe 
a new technology, the Ibis T5000, for the identification of pathogens in clinical and environmental 
samples; a novel ion channel switch biosensor (ICSB), offers a rapid and sensitive 
immunodiagnostic for viral detection at point-of care; Chip-NMR, new diagnostic platforms have 
been developed to measure biomolecule abundance with high sensitivity; Graphene has attracted 
strong scientific and technological interest in recent years. Finally, future trends in biosensor 
development are discussed. In this context, bioelectronics, miniaturization, and especially 
biotechnology seem to be growing areas that will have a marked influence on the development of 
new biosensing strategies in the next future. 
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Introduction 
There is a great need for a tool that can quickly, reliably, and 
accurately identify contaminating bioagents in the atmosphere. 
Biosensors can fundamentally serve as low-cost and highly well-
organized devices for this purpose in addition to being used in 
other day-to-day applications. (1) 
A biosensor is an integrated device that converts a molecular 
recognition event to a detectable physico-chemical signal. In 
general, the biosensor consists of a recognition element for the 
target (bio) chemical species and a transducer that is coupled to 
offer the output signal (2-4). 
The history of biosensors started in 1962 with the development of 
enzyme electrodes by Leland C. Clark. Since then, research 
communities from various fields such as very large scale 
integration (VLSI), physics, chemistry, and material science have 
come together to build up more sophisticated, reliable, and 
mature biosensing devices (1). Biosensors are defined as 
analytical devices incorporating a biological material, a biologically 
derived material (enzyme, antibody, receptor or microorganism), 
integrated within a physicochemical transducer or transducing 
microsystem (analytical device) (5). In contrast to chemical  
 
sensors, which are derived from synthetic compounds, most 
biosensors are constructed by using biomacromolecules, such as 
nucleic acids (DNA or RNA) or proteins, as the recognition 
platform (6-8). In particular, proteins characterize one of the most 
sophisticated biomacromolecules and play crucial roles in 
numerous biological processes to mediate and regulate a range of 
chemical reactions within cells. Biosensors are known as 
immunosensors, optrodes, chemical canaries, resonant mirrors, 
glucometers, biochips, and biocomputers. Two  commonly cited 
definitions by S. P. J. Higson and D. M. Frazer, respectively, are 
“a biosensor is a chemical sensing device in which a biologically 
derived recognition entity is coupled to a transducer, to allow the 
quantitative development of some complex biochemical 
parameter,”and “a biosensor is an analytical device incorporating 
a deliberate and intimate combination of a specific biological 
element (that creates a recognition event) and a physical element 
(that transduces the recognition event).”(1) 
Biosensors should be distinguished from a bioassay or a 
bioanalytical system, which require additional processing steps, 
such as reagent addition (9) and where the assay design is 
permanently fixed in the construction of the device. 
The name biosensor signifies that the device is a combination of 
two parts: a bioelement and a sensor element. The basic 
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concepts of a biosensor’s operation can be illustrated with the 
help of Fig. 1. A specific bioelement, such as an enzyme, 
recognizes a specific analyte and the sensor element transduces 
the change in the biomolecule into an electrical signal. The 
bioelement is very specific to the analyte to which it is sensitive. It 
does not recognize other analytes (1). 
Biosensors are being developed for different applications, 
including environmental and bioprocess control, quality control of 
food, military, medical applications and, particularly in bioterrorism 
detection and prevention. In fact, most of the commercially 
available biosensor systems are applied in the clinical and 
pharmaceutical markets. In addition, biosensor technology has 
been recently reviewed from the perspectives of agricultural 
monitoring (10), ground water screening (11), ocean monitoring 
(12) and global environmental monitoring (13). 
Accordingly, most research and development has been devoted 
to this area. In the food industry, the detection of contaminants, 
verification of product content, monitoring of raw materials 
conversion, and product freshness (14) are areas of potential 
biosensor application. The beer industry has already identified 
ways for improving and controlling their products through the use 
of biosensors (15). Biosensors can be also a defense tool through 
the early detection of hazardous materials such as germs. 
Biosensors have diversity in biomedical, industry, and military 
applications, as shown in Fig. 2. biosensors have tremendous 
potential for commercialization in other fields of application such 
as biosensor-based instruments in food and beverage production, 
environmental sampling, and noninvasive instruments or clinical 
analysis.(1) 
However, commercial adoption has been slow because of several 
technological difficulties. For example, due to the presence of 
biomolecules along with semiconductor materials, biosensor 
contamination is a major issue. consists of a bioelement and a 
sensor element. The bioelement may be an enzyme, antibody, 
living cells, or tissue. The sensing element can be electric current, 
electric potential, and so on. Different combinations of 
bioelements and sensor-elements constitute. The intention of this 
article is to converse recent advances and trends in the use of 
biosensors and related bioanalytical assays for monitoring 
applications. The trends and areas of advancement for various 
biorecognition elements are summarized in Table 1 
Basic concepts 
The bio and the sensor elements can be coupled as one of the 
four possible ways demonstrated as in: membrane entrapment, 
physical adsorption, matrix entrapment, and covalent bonding.  In 
the membrane entrapment scheme, a semipermeable membrane 
separates the analyte and the bioelement; the sensor is attached 
to the bioelement. The physical adsorption scheme is dependent 
on a combination of vander Waals forces, hydrophobic forces, 
hydrogen bonds, and ionic forces to attach the biomaterial to the 
surface of the sensor. The porous entrapment scheme is based 
on forming a porous encapsulation matrix around the biological 
material that helps in binding it to the sensor. In the case of the 
covalent bonding, the sensor surface is treated as a reactive 
group to which the biological materials can bind. The typically 
used bioelement enzyme is a large protein molecule that acts as a 
catalyst in chemical reactions but remains unchanged at the end 
of the reaction. (1) 
Biosensor structure 
A sensor can be defined as a device which responds to a physical 
stimulus producing a response which can be used for 
measurement, interpretation or control. The sensor is comprised 
of three essential components: the detector, which make out the 
physical stimulus; the transducer, which converts the stimulus to a 
useful, invariably electronic, output; and the output system itself, 
which involves amplification, display etc in an appropriate format 
(see figure 2). The term ‘biosensor’ is now generally applied to 
those devices which employ a biological/biochemical detection 
system. So, for example, a conventional pH meter operating in a 
fermentation process is not classified as a biosensor, whereas the 
detection of a potassium ion concentration by the antibiotic, 
valinomycin, is biosensing. Because the biological detection 
system or receptor, as it is commonly known, is the definitive 
component of the biosensor, it is essential to devote some 
discussion to receptors in this review, even if it falls outside the 
normal physics fare. This is done in the following section. The 
final component of the biosensor, the output system, is the 
domain of information technology, and while valuable of 
considerable effort as far as a finished product is concerned, is 
beyond the scope of this review (71). 
The second component of a biosensor, the transduction process 
is very much the domain of the physicist, but it is also important to 
consider the interface between the detector and the transducer, 
which often, in fact, constitutes the major hurdle in the 
development of a practical device (71). 
Biosensors can be classified according to three schemes: (i) the 
detector type, e.g. an immunosensor, (ii) the physics of the 
transduction process, e.g. an amperometric sensor, or (iii) the 
application, e.g. a medical biosensor. Each scheme can be useful 
in a particular context, though (ii) and (iii) are most commonly 
used (71). 
Receptors (detector) 
We have already acknowledged that the receptor, the 
biorecognition element, is the definitive component of the 
biosensor. It is also the most crucial, being responsible for the 
selective recognition of the analyte, generating the 
physicochemical signal monitored on the transducer and, in the 
end, the sensitivity of the device (72-73). Receptors can be 
categorized into two distinct types, catalytic, as typified by 
enzymes, and irreversible or affinitive, of which antibodies are the 
best-known example. A third group, amplified or hybrid 
configurations of the catalytic and affinitive types, can also be 
distinguished (71). 
 
Catalytic receptors: Among this class are single-enzyme systems, 
multiple enzymes, organelles, whole cells or organisms, and 
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slices of animal or plant tissue, the latter typically containing 
numerous enzymes and various cofactors with which they 
function more efficiently. Recently 20 different amino acids which 
are so structured as to grant a remarkable ability for catalysing 
specific reactions. This similar structure also limits their functional 
stability.                            
 
Affinity receptors: As opposed to catalytic receptors, the affinity 
classes are even more specific in the nature of the binding, with 
binding constants of 109–1012, but do not show catalytic activity. 
This fact has consequences for sensing applications. Affinity 
receptors are more suited to ‘one-shot’ detection rather than 
monitoring applications, since the binding is mostly irreversible. It 
is possible to break the binding complex, usually by changing the 
pH to 2, but this tends to decrease the affinity and specificity of 
the receptor. The high binding constant also favours the selective 
detection of very small analyte quantities (72)  
 
Hybrid receptors: Lowe et al (1990) have suggested that amplified 
receptor systems, involving a high-affinity recognition step 
followed by an amplification, cycling or cascade step, and 
therefore having characteristics of both the catalytic and 
irreversible receptors, will be capable of monitoring concentrations 
in the 10−12–10−15 range (72). 
Transduction techniques 
The second component of a biosensor, the transduction process 
is very much the domain of the physicist, but it is also important to 
consider the interface between the detector and the transducer, 
which often, in fact, constitutes the major problem in the 
development of a practical device (71). It is also the most crucial, 
being responsible for the selective recognition of the analyte, 
generating the physicochemical signal monitored on the 
transducer and, in the end, the sensitivity of the device (72-73). 
The use of piezoelectric transducers in biosensors was 
foreshadowed in the work of Sauerbrey (1959) who not only 
pioneered the use of the QCM but thoroughly analysed the 
physics of the device. The concern in this work was purely in 
determining the thickness of thin layers adhering to a surface by 
microweighing. One of the major advantages of optical sensors is 
their ability to probe surfaces and films in a non-destructive 
manner. Additionally, they offer advantages in speed, safety, 
sensitivity and robustness, as well as permitting in situ sensing 
and realtime measurements. An optical immunosensor consists of 
either an antibody or antigen immobilized on a suitable surface. 
The primary function of this type of sensor is to produce a 
measurable signal upon interaction with a biospecific 
immunological component.  
Common types of biosensors 
In resonant biosensors, an acoustic wave transducer is coupled 
with an antibody, or bioelement. When the analyte molecule, or 
antigen, gets attached to the membrane, the mass of the 
membrane changes. The resulting change in the mass 
subsequently changes the resonant frequency of the transducer. 
This frequency change is then measured. There are many types 
of biosensors, few biosensors are  classified here in detail on the 
basis of receptors and transducer (74). 
On the basis of Bioreceptors some Biosensors 
are classified as follows: 
Biomolecule immobilization 
 A biosensor is an analytical device containing an immobilized 
biological sensitive material (enzyme, antibody, antigen, 
organelles, DNA, cells, tissues or organic molecules) in contact 
with or integrated within a transducer (piezoelectric, acoustic, 
optical, calorimetric or electrochemical), which finally converts a 
biological signal into a quantitatively measurable electrical signal. 
The usual aim is to produce a thin film of immobilized biologically 
active material on or near the transducer surface which responds 
only to the presence of one or a group of materials or substances 
requiring detection. Despite the initial loss in activity, recent 
advances in biosensor immobilization technologies have resulted 
in biosensors being stored for periods up to a year without further 
loss in sensitivity. Since the immobilization technique used to 
attach the biological material to the sensor surface is crucial to the 
operational behaviour of the biosensor, realistic strategies for the 
development of immobilization techniques are essential for 
practically useful biosensor. 
There are a number of requirements that the immobilization 
technique must satisfy if biosensors are to be of practical use: (i) 
the biological component must retain substantial biological activity 
when attached to the sensor surface; (ii) the biological film must 
remain tightly associated with the sensor surface whilst retaining 
its structure and function; (iii) the immobilized biological film needs 
to have long-term stability and durability; and (iv) the biological 
material needs to have a high degree of specificity to a particular 
biological component. These conditions must be satisfied for an 
efficient sensing device. 
Therefore, an important aspect of biosensor development, 
especially affinity based biosensors, is the ability of the 
immobilization technique used to afford the desired distribution 
and/or orientation of biological molecules once immobilized (75). 
The incorporation of biological components in membrane 
structures was first described by Clark and Lyons (1962). Since 
that pioneering work, in which an enzyme-based  glucose sensor 
was developed by the entrapment of glucose oxidase in a 
membrane enclosed sandwich, there have been a number of 
methods which have been described for the immobilization of 
enzymes and proteins on surfaces and within various matrices 
(76). The principal methods of immobilization are: 
(1) physical or chemical adsorption at a solid surface; 
(2) covalent binding to a surface; 
(3) entrapment within a membrane, surfactant matrix, polymer or 
microcapsule; 
(4) cross-linking between molecules. 
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In addition to these conventional methods, more recently the 
methods of sol–gel entrapment, Langmuir–Blodgett (LB) 
deposition and electropolymerization have all been extensively 
used to immobilize biological components. The immobilization 
method employed will depend on a number of factors, but in 
general the method needs to be compatible with the biomolecule 
being immobilized, the sensor surface or matrix on which 
immobilization is to proceed, and, ultimately, the end use of the 
sensor. Adsorption of biomolecules from solution onto solid 
surfaces can proceed via either physical or chemical interactions. 
Physical adsorption involves van der Waals forces, ionic binding 
or hydrophobic forces, whereas in chemisorption there is a 
sharing or transfer of electrons to form a chemical bond. In early 
work, immobilization by adsorption was used successfully to 
couple proteins to various solid substrates, including derivatized 
glass, plastics and silicone rubber (77). More recent work has 
focused on the binding of biomolecules onto metal surfaces for 
biosensing applications.  
Enzyme-based biosensors 
A wide range of biomolecular  recognition elements have been 
used for biosensors for potential environmental applications. 
These can be organized by structural (e.g, enzyme, antibodies or 
microorganisms) or functional (e.g, catalytic, complex cellular 
functions) characteristics. There are numerous advantages for 
enzyme biosensors. These include a stable source of material 
(primarily through biorenewable sources), the ability to modify the 
catalytic properties or substrate specificity by means of genetic 
engineering, and catalytic amplification of the biosensor response 
by modulation of the enzyme activity with respect to the target 
analyte. There are also some limitations for enzyme-based 
biosensors with respect to environmental applications. These 
include the limited number of substrates for which enzymes have 
been evolved, the limited interaction between environmental 
pollutants and specific enzymes, and in the case of inhibitor 
formats, the lack of specificity in differentiating among compounds 
of similar classes such as nerve agents as well as 
organophosphate (OP) and carbamate pesticides. 
Recent progress with respect to enzyme biosensors for 
environmental applications has been reported in several areas. 
These areas include the following; genetic modification of 
enzymes to increase assay sensitivity, stability and shelf life; 
improved electrochemical interfaces and mediators for more 
efficient operation; and introduction of sampling schemes 
consistent with potential environmental applications (78). 
Antibody-based biosensors 
Antibody-based biosensors (immunosensors) are inherently more 
versatile than enzyme-based biosensors in that antibodies have 
been generated which specifically bind to individual compounds or 
groups of structurally related compounds with a wide range of 
affinities. There are, however, several limitations in the use of 
antibody-based biosensors for monitoring applications. These 
limitations include the complexity of assay formats and the 
number of specialized reagents (e.g, antibodies, antigens, tracers, 
etc.) that must be developed and characterized for each 
compound and the limited number of compounds typically 
determined in an individual assay as compared to the multiple 
compounds that contaminate environmental samples (78). 
Recent advances reported for antibody-based biosensors for 
environmental applications have primarily been focused toward 
these limitations. For example, the simultaneous detection of six 
hazardous bacteria and protein toxins was demonstrated on a 
planar waveguide array biosensor (79). The biohazards included 
ricin, cholera toxin, F. tularensis, B. adortus, B. anthrasis and 
eneterotoxin B from S. aureus in the presence of environmental 
contaminants such as sand, clay, pollen and smoke. The 
instrumentation was automated and the assay was compatible for 
development as a field assay. 
Cell-based biosensors 
Cell-based biosensors for environmental applications can be 
organized according to cell type. For example, bacteria, yeast, 
algae and tissue culture cells. Although there are numerous 
examples of genetic modification to these cell types, genetically 
engineered bacteria (GEMs) are most often reported in cell-based 
biosensors (80). Bacteria have been genetically engineered to 
construct gene fusions typically composed of a regulatory system 
(i.e., native promoter) linked to a reporter(s) genes. For these 
genetically modified microorganisms often referred to as 
’biosensors’ or ’bioreporters’, the presence of an effector 
(nonspecific stressor or biochemically active compound or toxin) 
results in a cascade of events that produces some measurable 
response. Effectors for which bioreporters have been constructed 
include: non-specific stressors such as DNA damage, gamma 
radiation, heat shock, and oxidative stress; toxic metals such as 
cadmium, chromate, cobalt, copper, iron, lead, mercury, nickel 
and zinc; organic environmental pollutants such as chlorinated 
aromatics, benzene derivatives, organic peroxides, 
trichloroethylene and PCBs; and compounds of biological 
importance such as nitrate, ammonia and antibiotics (81).  
Genetically engineered microbial and cell-based biosensors show 
several advantages and limitations with respect to potential 
environmental applications. Limitations primarily involve the 
maintenance of their environment (i.e, nutrients, O2, pH, ionic 
strength, etc.) and the time required for a response. Recent 
advances in reporter microorganisms have involved novel fusions 
of a wide range of promoters with conveniently measured 
reporters, as well as the construction of unique sensing platforms 
that can be used to study individual organisms as well as 
population responses (78). 
DNA biosensors 
Due to their wide range of physical, chemical and biological 
activities, nucleic acids have been incorporated into a wide range 
of biosensors and bioanalytical assays, many of which show the 
potential for adaptation (82). In addition to these genetically 
unrelated uses of DNA for biosensors, a number of biosensors 
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and bioassays have been reported for the detection of chemically-
induced DNA damage. There is also an ongoing attempt in the 
area of biosensor technology for measuring DNA hybridization 
prerequisite for genetic identification of pathogenic 
microorganisms. The measurement of DNA damage using 
electrochemical biosensors has been demonstrated using the 
direct measurement of oxidation–reduction properties of the 
bases (83, 84) or indirectly using electrochemical probes (85). 
These biosensors have been used to measure toxic aromatic 
amines (84), oxidative damage (85, 86), and bioactivated 
benzo(a)pyrene (87). DNA damage can also been measured 
using fluorescence-based biosensors and bioanalytical 
techniques. In recent report, DNA adducts of benzo(a)pvrene 
were measured using low temperature fluorescence on a gold 
biosensor chip (88). This rapid screening assay was sensitive to a 
variety of forms of DNA damage, including strand breaks, 
crosslinks and adduct formation. DNA hybridization microarrays 
have been recommended as a platform for the parallel detection 
of multiple pathogenic microorganisms relevant to both 
biodefense and environmental contamination applications (89). 
The technology required for this type of application would require 
that biosensors be rapid, sensitive, and compatible with profitable 
development. Examples of this approach have been 
demonstrated in food industry. DNA microarray techniques have 
been reported for the simultaneous detection of virulence factors 
in their food borne pathogens (90). Advances in the progress of 
hybridization biosensors have also included a visual DNA chip for 
detection of hepatitis virus (91), lead labeled oligonucleotides 
detected hybridization is used by anodic stripping voltammetry 
(92), hybridization using gold nanoparticles by optical detection 
(93), and DNA hybridization using silver precipitation on gold 
nanoparticle-labeled oligonucleotides by electrochemical 
detection (94,95). Although these biosensors and array 
techniques were not specially developed for environmental 
applications, this type of technology is prerequisite for 
development of DNA-based biosensors for environmental 
applications. 
On the basis of Transducers some Biosensors 
are Classified as follows : 
Electrochemical biosensors 
These devices are mainly based on the observation of current or 
potential changes due to interactions occurring at the sensor- 
sample matrix interface. This device was applied to the fast 
glucose assay in blood samples from diabetics. At present, there 
are many proposed and already commercialized devices based 
on the biosensor principle including those for pathogens and 
toxins, some even based on a multi-channel configuration (96, 
97). The most typical part of electrochemical biosensors is the 
presence of a suitable enzyme in the biorecognition layer 
providing electroactive substances for detection by the physico-
chemical transducer providing the measurable signal. A rather 
limited number of enzymes processed in biotechnology were 
chosen for the monitoring of clinical metabolites and, especially 
from the group of oxidoreductases: glucose oxidase (98) and 
glucose dehydrogenase (99) for glucose assays and cholesterol 
oxidase co-immobilized with cholesterol esterase for the 
cholesterol assay (100). Peroxidase and alkaline phosphatase are 
the most common enzyme labels for electrochemical affinity 
biosensors (101). Compared to optical methods, electrochemistry 
allows the analyst to work with turbid samples, and the capital 
cost of equipment is much lower. On the other hand, 
electrochemical methods present slightly more limited selectivity 
and sensitivity than their optical counterparts. Techniques are 
generally classified according to the observed parameter: current 
(amperometric), potential (potentiometric) or impedance 
(impedimetric). 
Amperometric methods 
 
This is perhaps the most common electrochemical detection 
method used in biosensors. It works on the grounds of an existing 
linear relationship between analyte concentration and current. The 
sensor potential is set at a value where the analyte, directly or 
indirectly, produces a current at the electrode. In the case of 
biosensors, where direct electron exchange between the 
electrode and either the analyte or the biomolecule is not 
permitted, redox mediators are required (102). Redox mediators 
are small size compounds able to reversibly exchange electrons 
between both the sensor and the enzyme of choice (e.g., 
ferricyanide, osmium or ruthenium complexes, dyes, etc.). Many 
different combinations and strategies to build biosensors are 
possible. The actual choice depends on constraints imposed by 
sample matrix, analyte, or usability. Bacterial biosensors do not 
differ much from more conventional biosensors (103). In this work, 
E. coli is detected in 30 min and between 100 and 600 cellsmL−1 
using a flow-through immunofiltration method coupled to 
amperometry. (104)  
Potentiometric methods 
These are the least common of all biosensors, but different 
strategies may be found nonetheless (105). For example, they 
may consist of an ion selective membrane and some bioactive 
material, e.g., an enzyme. The enzyme catalysed reaction 
consumes or generates a substance which is detected by the ion-
selective electrode. Since potentiometry yields a logarithmic 
concentration response, the technique enables the detection of 
extremely small concentration changes. Another approach 
involves the use of suitably modified ion selective field effect 
transistors (ISFETs) (106) which utilise the semiconductor field-
effect to detect biological recognition events. ISFETs use an 
electric field to create regions of excess charge in a 
semiconductor substrate in order to enhance or decrease local 
conductivity. They consist of a p-type silicon substrate with two n-
doped regions known as source and  drain, separated by a short 
distance (gate) covered by a layer of insulator. The gate insulator 
is typically SiO2 and it is covered by an ion selective membrane 
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which is selectively permeable to a certain ion, e.g., K+, Ca2+, F−, 
as described in (107). The application of these devices in the area 
of biosensors is reasonably new (105) and their use is not 
spreading as quickly as other electrochemical techniques due to, 
amongst others (i) problems related to production which include 
incompatibility of most biomolecule immobilization methods with 
the ISFET fabrication technology and difficult packaging and 
encapsulation at wafer level, (ii) poor detection limits, linear range 
and reproducibility and (iii) inadequate device stability (104). 
Electrochemical impedance spectroscopy (EIS) 
 
Impedance spectroscopy represents a powerful method for the 
study of conducting materials and interfaces. In this technique, a 
cyclic function of small amplitude and variable frequency is 
applied to a transducer, and the resulting current is used to 
calculate the impedance (108) at each of the frequencies probed.  
The most rigorous approach involves solving the system of partial 
differential equations governing the system. The second way, 
which is often preferred because of its relative simplicity, consists 
in the interpretation of the data in terms of equivalent circuits. The 
latter are made up of a combination of capacitors and resistors 
suitably arranged. Although this methodology is widely accepted 
because of ease of use, extreme care must be taken to ensure 
that the equivalent circuit obtained makes physical sense. An 
advantage of EIS compared to amperometry or potentiometry is 
that labels are no longer necessary, thus simplifying sensor 
preparation. Along these lines, Alocilja et al. reported a 
conductimetric method using polyclonal antibodies against E. coli 
(109).  Although impedimetric techniques are very promising, a lot 
of work is still needed in order to bring the technique up to a 
competitive level. Even the fundamental understanding of the 
phenomena involved in this type of immunosensors is largely to 
be developed. For instance, studies of the effect of electrode size 
and their separation distance has not been found in the recent 
literature, but it is not entirely unreasonable to believe that using 
the appropriate electrode configuration and sample pre-treatment 
steps, detection limits below 103 CFUmL−1 could be achieved 
(104). 
Optical Biosensor 
These are probably the most popular in bioanalysis, due to their 
selectivity and sensitivity. Optical biosensors have been 
developed for rapid detection of contaminants, toxins or drugs and 
even pathogen bacteria. Recently, fluorescence and surface 
plasmon resonance, SPR, based methods have gained 
momentum because of their sensitivity (104). 
Fluorescence detection 
 
Fluorescence occurs when a valence electron is excited from its 
ground state to an excited singlet state. The excitation is 
produced by the absorption of light of sufficient energy. When the 
electron returns to its original ground state it emits a photon at 
lower energy. Another important feature of fluorescence is the 
little thermal loss and rapid (<10 ns) light emission taking place 
after absorption. The emitted light is at a longer wavelength than 
the absorbed light since some of the energy is lost due to 
vibrations, this energy gap is termed Stoke’s shift, and it should 
be large enough to avoid cross talk between excitation and 
emission signals. Antibodies may be conjugated to fluorescent 
compounds, the most common of which is fluorescein 
isothiocyanate (FITC) (110). There are, however, other 
fluorescent markers. The use of lanthanides as sources of 
fluorescence in luminescent assays has very recently been 
reviewed (111). Although lanthanides pose several important 
advantages (good stability, low background luminescence under 
normal light conditions and large Stoke’s shift) compared to more 
traditional fluorophores, their use is very restricted due to safety 
reasons. Fluorescence detection, in contrast to SPR, is also used 
in combination with established techniques such as PCR and 
ELISA. Such is the case of a hand-held real-time thermal cycler 
recently developed (112). This analyser measures fluorescence at 
490 and 525 nm, which enables the simultaneous detection of 
more than one microorganism. Although this work claims 
detection times of 30 min, it should be pointed that overnight 
culturing is required to achieve best results. Fluorescence 
resonance energy transfer (FRET) biosensors are based on the 
transfer of energy from a donor fluorophore to an acceptor 
fluorophore (104). 
Surface plasmon resonance 
SPR biosensors (113) measure changes in refractive index 
caused by structural alterations in the vicinity of a  thin film metal 
surface. Current instruments operate as follows. A glass plate 
covered by a gold thin film is irradiated from the backside by p-
polarised light (from a laser) via a hemispherical prism, and the 
reflectivity is measured as a function of the angle of incidence, θ. 
The resulting plot is a curve showing a narrow dip. This peak is 
known as the SPR minimum. The angle position of this minimum 
is determined by the properties of the gold-solution interface. 
Hence, adsorption phenomena and even antigen–antibody 
reaction kinetics can be monitored using this sensitive technique 
(as a matter of fact, SPR is used to determine antigen–antibody 
affinity constants). The main drawbacks of this powerful technique 
lay in its complexity (specialized staff is required), high cost of 
equipment and large size of most currently available instruments 
(although portable SPR kits are also available commercially, as is 
the case of Texas Instruments’ Spreeta system). SPR has 
successfully been applied to the detection of pathogen bacteria by 
means of immunoreactions (114, 115). 
Piezoelectric biosensors (mass based) 
 
According to the modern definition, a biosensor is an analytical 
device comprising a biological or biologically derived sensing 
element either integrated within or intimately associated with a 
Bhadoria et al. International Journal of Drug Delivery 3 (4) 571-585 [2011] 
 
PAGE | 577 | 
 
 
physicochemical transducer (116). In affinity sensors a 
stoichiometric binding event takes place and the associated 
physicochemical changes are detected by an appropriate 
transducer (117). The transducers which are mainly used in the 
development of affinity biosensors are piezoelectric- and optical- 
based techniques. Together with piezoelectric transduction, some 
optical approaches have the advantage of not requiring the use of 
labels such as radioactive or fluorescent tags, and of recording in 
real-time the affinity reaction allowing also kinetic studies (118). 
The term ‘‘piezoelectric’’ derived from the Greek word piezen 
meaning ‘‘to press.’’ The first investigation on the piezoelectricity 
was performed in 1880 by Jacques and Pierre Curie (119), who 
observed that a mechanical stress applied to the surfaces of 
various crystals, caused a corresponding electrical potential 
across the crystal, whose magnitude was proportional to the 
applied stress. Application of an alternating electric field across 
the crystal substrate results in an alternating strain field. This 
causes a vibrational, or oscillatory, motion in the crystal, resulting 
in the generation of acoustic standing waves. Recently, however, 
the interest in the application of piezoelectric devices in the field of 
analysis has increased, since it was realized that many 
opportunities for molecular sensing can be opened up once a 
suitable recognition layer or molecule is coated on the crystal. In 
particular, piezoelectric biosensors have found a wide range of 
applications in food, environmental and clinical analysis (120). 
DNA piezoelectric biosensors 
The biorecognition elements that are normally employed in the 
realization of an affinity biosensor are antibodies, receptors or 
nucleic acids. In recent years, nucleic acids have received 
increasing interest as bioreceptors for biosensors and biochips for 
specific sequence detection (120). The biorecognition 
mechanism, generally, involves hybridization of deoxyribonucleic 
acid (DNA) or ribonucleic acid (RNA). The complementory of 
adenine:thymine (A:T) and cytosine:guanine (C:G) pairing in DNA 
forms the basis for the specificity of biorecognition in DNA 
biosensors. These biosensors are often based on the 
immobilization of a fragment of DNA with a specific sequence 
(probe) and on the monitoring and recording the variation of the 
transducer signal when the complementary fragment (target) in 
solution hybridizes with the probe.The first report on the direct 
detection of nucleic acid interactions based on the use of acoustic 
wave devices was provided by Fawcett et al. (121). A large 
amount of work in this field has been produced by Thompson and 
colleagues (122) who investigated RNA–protein, DNA–DNA 
(123), and RNA–RNA (124) interactions. 
Immobilization of nucleic acids 
 
Probe immobilization is a fundamental step in DNA based 
piezoelectric biosensor development. Often, the detection limits 
and, in general, the analytical performances of the biosensor can 
be improved by optimizing the immobilization procedure on the 
quartz surface (125,126). Actually, the limitation of QCM devices 
is nonspecific adsorption of molecules present in real matrices, 
since QCM is a mass sensor and any molecule able to bind or to 
be adsorbed on the surface is a potential interference. Moreover, 
receptors, in this case DNA, must be attached to the solid support 
retaining native conformation and binding activity. Moreover, 
many published papers showed that immobilization techniques 
based on direct adsorption or on protein coating, resulted in 
appropriate sensor signals, but only crosslinker procedures using 
thiols or the interaction between avidin and biotinylated 
molecules, provided a long sensor lifetime and an increased 
stability against degradation during the regeneration process 
(127). Moreover, the hybridization reaction between the 
immobilized probe and the target sequence in solution is also 
described and specific applications are presented. The examined 
immobilization methods allow also the reuse of the sensor, by 
dissociation of the double stranded DNA, maintaining the probe 
bound to the sensor surface, ready for a new measurement cycle. 
Other Biosensors 
ESI–MS  Based biosensor 
Recently, Ibis T5000 biosenor used for the identification of 
pathogens in clinical and environmental samples. The Ibis T5000 
couples nucleic acid amplification to high-performance 
electrospray ionization mass spectrometry and base-composition 
analysis. The system enables the identification and quantification 
of a broad set of pathogens, including all known bacteria, all major 
groups of pathogenic fungi and the major families of viruses that 
cause disease in humans and animals, along with the detection of 
virulence factors and antibiotic resistance markers. The Ibis 
T5000 is a universal biosensor. The mass spectrometer 
component of the Ibis T5000 enables more information to be 
extracted from PCR reactions than can be obtained with standard 
individual probes. This enriched information extraction occurs in 
two dimensions simultaneously. First, a large number of PCR 
amplicons can be analysed. This enables the use of PCR primers 
that amplify groups of organisms in mixed populations, rather than 
single species. 
For example, primers for viruses can be designed to encompass 
entire viral families that comprise hundreds of characterized 
species, and primers for bacteria can be designed that 
encompass the entire bacterial domain of life. Second, a large 
amount of information is obtained from each individual amplicon 
by mass spectrometry. The mass spectrometer weighs each 
amplicon with sufficient accuracy that the composition of 
nucleotides (As, Gs, Cs and Ts) can be unambiguously 
determined. Although not as information rich as the sequence (the 
linking order is not determined using ESI–MS), for many 
diagnostic purposes, the nucleotide composition of a nucleic acid 
can have the same practical value. For example, when a small set 
of primers is strategically chosen, approximately six PCR 
reactions can yield sufficient information to identify the bacteria 
that are present to the species level2. For viruses, primers can be 
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designed to encompass broad genera, such as Alphaviruses3 or 
Mastadenoviruses4, or even whole virus 
families, such as the Orthomyxoviridae5 or Coronaviridae6. When 
primers are designed to amplify all known members within a 
target group, previously uncharacterized members are also 
detected. This is a crucial advantage of the Ibis T5000 technology 
relative to probe based molecular methods, for which anticipation 
of the target nucleic acid sequence is required to design the probe 
(128). 
Ion Channel Switch Biosensor 
Cornell (2002) and Cornell et al. (1997) recently developed a 
novel ion channel switch biosensor (ICSB) which offers a rapid 
and sensitive immunodiagnostic for viral detection at point-of care 
(129,130). The ICSB uses a simple electrical reader for objective 
measurement, unlike commercially available optically read kits 
that require subjective interpretation of the test results. The ICSB 
offers the additional advantage that it does not require the time-
consuming steps of specimen extraction, washing and incubation 
which are essential in currently used approaches such as enzyme 
linked immunosorbent assays (ELISA) (131) or the polymerase 
chain reaction (PCR) test (132, 133). The ICSB employs a bilayer 
lipid membrane (BLM) and the ion channel molecule gramicidin A, 
tethered via disulphide groups to a gold surface. The membrane 
is separated from the gold surface by ethylene glycol spacer 
molecules which provides a reservoir for ions to pass through the 
gramicidin ion channel. Target specific antibody Fab fragments 
are attached to the mobile gramicidin molecules in the outer 
monolayer leaflet and to other non-ion channel sites tethered to 
the electrode surface. The arrival of the target analyte crosslinks 
the antibodies attached to the mobile outer layer channels, to 
those attached to other fixed sites on the membrane surface. Due 
to the low density of tethered channels within the inner membrane 
leaflet, the cross-linking of the antibodies by the target molecules 
causes the outer layer channels to be anchored away from their 
tethered inner layer partners. Gramicidin dimer alignment is thus 
prevented, disrupting the current across the membrane (134).  
Chip–NMR biosensor  
A number of new diagnostic platforms have been developed to 
measure biomolecule abundance with high sensitivity (135), 
enable early disease detection and gain valuable insights into 
biology at the systems level. Some examples include nuclear 
magnetic resonance (NMR) with hyperpolarized gas, nanowire 
and nanoparticle sensors, surface plasmon resonance devices 
and mass spectrometry. Many of these devices and techniques, 
however, requiring time-consuming purification of samples 
typically followed by a set of amplification strategies, may lack the 
ability for the multiplexed measurements that are desirable in 
identifying complex diseases (135,136)  or may not be amenable 
for easy point-of care translation. Here we report a chip-based 
diagnostic magnetic resonance (DMR) system for rapid, 
quantitative and multichanneled detection of biological targets. 
Using readily available magnetic nano- and microparticles as a 
proximity sensor to amplify molecular interactions, the DMR 
system can perform highly sensitive and selective measurements 
on small volumes of unprocessed biological samples. When a few 
magnetic nanoparticles bind their intended molecular target 
through affinity ligands, they form soluble nanoscale clusters, 
which leads to a corresponding decrease in the bulk spin-spin 
relaxation time (T2) of surrounding water molecules. These 
advantages render the proximity assay ideal for fast, simple and 
high-throughput sensing operations, especially in miniaturized 
device format. To date, however, measurements have relied 
primarily on clinical or bench top NMR systems requiring large 
sample volumes and complex data acquisition. Miniaturizing an 
entire NMR system, including the source of external magnetic 
fields, was technically challenging, mainly owing to the low NMR 
signal level intensity coming from the small sample volume and 
low magnetic field strength. We have overcome these limits by 
optimizing the design of the NMR system and by introducing 
microfluidics onto the NMR chip (137). 
Graphene Based Electrochemical Biosensor 
Graphene has attracted strong scientific and technological interest 
in recent years (138-143). It has shown great promise in many 
applications, such as electronics, energy storage and conversion 
(supercapacitors, batteries, fuel cells, solar cells), and 
bioscience/biotechnologies because of its unique physicochemical 
properties: high surface area (theoretically 2630 m2/g for single-
layer graphene) (138, 142), excellent thermal conductivity and 
electric conductivity, and strong mechanical strength. Many 
methods have been developed to produce grapheme. In 2004, 
Geim and coworkers (144) first reported graphene sheets 
prepared by mechanical exfoliation (repeated peeling) of highly 
oriented pyrolytic graphite. This method, which is called scotch-
tape method (141,142), is still widely used in many laboratories to 
obtain pristine perfectstructured graphene layer(s) for basic 
scientific research and for making proof-of-concept devices. Most 
of graphene used in electrochemistry are produced with the last 
method of GO reduction. Graphene from GO reduction, which is 
also called functionalized graphene sheets or chemically reduced 
graphene oxide, usually has abundant structural defects and 
functional groups which are advantageous for electrochemical 
applications (145).  
Graphene-Based Electrochemical Sensors 
The excellent electrochemical behaviors of graphene indicate 
graphene is a promising electrode material in electroanalysis 
(146,147). Several electrochemical sensors based on grapheme 
and graphene composites for bioanalysis and environmental 
analysis have been developed (145). 
 
Graphene-Based Enzyme Biosensors 
On the basis of the high electrocatalytic activity of graphene 
toward H2O2 and the excellent performance for direct 
electrochemistry of GOD, graphene could be an excellent 
electrode material for oxidase biosensors. Zhou et al. reported a 
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glucose biosensor based on chemically reduced graphene oxide 
(CR-GO). Graphene (CR-GO)-based biosensor exhibits 
substantially enhanced amperometric signals for sensing glucose: 
wide linear range (0.01 – 10 mM), high sensitivity and low 
detection limit of 2.00 mM. The linear range for glucose detection 
is wider than that on other carbon materials-based electrodes, 
such as carbon nanotubes (148) and carbon nanofibers. The 
response atthe GOD/CR-GO/GC electrode to glucose is very fast 
and highly stable (91% signal retention for 5 h), which makes 
GOD/CR-GO/GC electrode a potential fast and highly stable 
biosensor to continuously measure the plasma glucose level for 
the diagnosis of diabetes. Graphene/metal nanoparticles (NP) 
based biosensors have also been developed. Shan et al. reports 
a graphene/AuNPs/chitosan composites film based biosensor 
which exhibited good electrocatalytical activity toward H2O2 and 
O2. Wu et al. (149) reports GOD/graphene/ PtNPs/chitosan based 
glucose biosensor with a detection limit of 0.6 mM glucose. These 
enhanced performance were attributed to the large surface area 
and good electrical conductivity of graphene, and the synergistic 
effect of graphene and metal nanoparticles (145). 
 
Graphene-Based Electrochemical DNA 
Biosensors 
Electrochemical DNA sensors offer high sensitivity, high 
selectivity and low cost for the detection of selected DNA 
sequences or mutated genes associated with human disease, and 
promise to provide a simple, accurate and inexpensivie platform 
of patient diagnosis (150). Electrochemical DNA sensors also 
allow device miniaturization for samples with a very small volume. 
Among all kinds of electrochemical DNA sensors, the one based 
on the direct oxidation of DNA is the simplest (145).  
Future Prospects and Challenges 
Biosensors for potential environmental applications continue to 
show advances in areas such as genetic modification of enzymes 
and microorganisms, improvement of recognition element 
immobilization and sensor interfaces, and introduction of 
improved operational formats and unique environmental 
applications. The use of genetically modified AChE in biosensors 
has significantly increased their sensitivity to inhibition by OP 
pesticides (151-153). Furthermore, genetic modification shows the 
potential for selection of enzyme variants that are specific for a 
range of individual compounds. Novel gene fusions have resulted 
in more sensitive and versatile reporters such as GFP and show 
the potential for construction of a battery of organisms that 
respond to a wide range of physical and chemical stressors using 
a single detection platform. One area where continued progress 
could yield significant advances for environmental applications 
would be to better characterize bioreporter organisms as 
surrogates for human exposure. Better methods for immobilization 
of enzymes and antibodies to sensor surfaces continue to 
increase the robustness and improve prospects for 
commercialization of biosensors for environmental applications. 
Future advances in immobilization will likely focus on directing 
biorecognition elements to addressable locations on micro or 
nano-sensor arrays (154). One of the challenges that must be met 
for this type of system would be the development of parallel 
computational methods to convert electronic responses for each 
analyte into important concentration data. In this respect progress 
has been reported for automated sensor systems that operate in 
environment (155). A biosensor approach toward measuring 
genetic damage has involved the detection of chemically-induced 
damage to DNA (156). One of the challenges for this area will be 
the development of environmental applications associated to 
ecosystem and human exposure to genotoxins. This would 
require the isolation and analysis of DNA, genotoxic substance 
after exposing with the organism. This type of application would 
also require both, extent of DNA damage with high sensitivity and 
the amount of DNA required for the analysis. The development of 
biosensors receptive to biochemical responses are also a trend 
where important advances are likely to be made in the future. For 
example, a range of receptor-based biosensors that are receptive 
to estrogenic and endocrine disrupting compounds have been 
reported (157– 159). The challenge in this case will be to calibrate 
the biosensor response to the risk of adverse biological effect 
rather than simply receptor binding affinity. Biosensor techniques 
for potential environmental applications have continued to show 
sustained advances in a wide range of areas. It is also likely that 
these advances will play an important role in the development of 
biosensor systems for the environmental market. Nevertheless, 
until biosensors achieve operational characteristics similar to the 
simple pH electrode in terms of durability, selectivity, extended 
concentration range, and resistance to biofouling, they will likely 
continue to experience significant obstacles to widespread 
acceptance and use for environmental monitoring. Nevertheless, 
there are a number of areas where the unique capabilities of 
biosensors might be exploited to meet the requirements of 
environmental monitoring. Advances in areas such as toxicity, 
bioavailability-, and multi-pollutant-screening, could widen the 
potential market and allow these techniques to be more 
competitive. Miniaturization, reversibility and continuous operation 
may allow biosensor techniques to be incorporated as detectors in 
chromatographic systems. Because in many cases the 
transduction technology is well established, most of the research 
is focused on improving immobilization techniques of the 
biological element to increase sensitivity, selectivity, and stability. 
While critical, the latter has received relatively little attention 
probably in part because there is a tendency to design disposable 
devices that are most useful in quality assurance laboratories but 
do not allow on-line implementation for process control. Another 
dynamic area of research is miniaturization of sensors and flow 
systems. Development of these technologies is mainly driven by 
the need for in vivo applications for medical diagnosis and may 
not find immediate use in the agricultural and food industries. 
After almost 40 yr of research in biosensors, a wide gap between 
research and application is evident. The lack of validation, 
standardization, and certification of biosensors has resulted in a 
very slow transfer of technology. With faster computers and 
automated systems this process should accelerate in the future. 
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Figure 2. Schematic of a biosensor. 
 
 
 
 
 
 
 
  
 
 
 
                                                                                                                               
 
 
 
 
 
 
 
 
 
Fig 3. Schematic of Biosensor Classification Schemes 
Analyte 
Bioelement Transducer Bioelement 
BIOSENSORS 
Bioreceptors Transducer
Enzyme DNA Cell Bioimmbilization Optical Electrochemical Massbased Others Antibody 
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Table 1: 
Areas of advancement for biorecognition elements 
 
Biorecognition element  
Area of advancement 
 
Reference 
Enzyme 
 
Genetic modification for improvement of 
sensitivity and stability. 
Improvement of sensor interface. 
Improvement of operational format and unique 
environmental applications. 
[16-18] 
 
[19–24] 
 
[25–30] 
Antibody Multi-analyte detection. 
Automation and demonstrated environmental 
applications. 
Reversible binding and simplified or improved 
format. 
[31-34] 
 
[33,34] 
 
[35–39] 
Cellbased 
 
 
 
Novel gene fusions responsive to specific 
compound classes and assay format 
improvements. 
Novel gene fusions responsive to toxic or 
genotoxic stressors. 
Native organisms responsive to specific 
compounds, toxic stressors and biological 
oxygen demand. 
[40–42,43,44] 
 
 
[45–46] 
 
 
[47,48–53] 
DNA DNA damage. 
DNA hybridization and detection of pathogens. 
[54–58] 
 
[59–62] 
Receptors Estrogenic and endocrine disrupting 
compounds 
[63–70] 
 
 
Electrochemical 
biosensors 
Amperometric biosensor  
 
Potentiometric Biosensor Impedimetric Biosensor 
